← 產業報告目錄

Neurovascular Embolization Devices Market Size, Share & Trends Analysis Report By Product Type (Aneurysm Clips, Liquid Embolic Systems, Flow Diversion Stents, Embolization Coils, Intrasaccular Flow Disruptors), By End-User, By Region, And By Segment Forecasts, 2024-2031

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-17頁數 190報告編號 INSIGHTACE-9cebac6f6b

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

With a 2023 valuation of USD 1.44 Billion, the global Neurovascular Embolization Devices Market is expected to advance to USD 2.41 Billion by 2031, demonstrating a CAGR of 6.75% during the 2024–2031 forecast window. The Neurovascular Embolization Devices sector involves These coils are prescription equipment implanted into the aneurysm sac by a physician to block blood flow and promote thrombosis. This domain has witnessed pronounced transformation owing to technological breakthroughs and shifting healthcare dynamics. Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives. From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities. Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases. Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing. Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Neurovascular Embolization Devices Market Snapshot Chapter 4. Global Neurovascular Embolization Devices Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis 5.1. By Product Type, & Market Share, 2023 & 2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type: 5.2.1. Aneurysm Clips 5.2.2. Liquid Embolic Systems 5.2.3. Flow Diversion Stents 5.2.4. Embolization Coils 5.2.5. Intrasaccular Flow Disruptors Chapter 6. Market Segmentation 2: By End-User Estimates & Trend Analysis 6.1. By End-User & Market Share, 2023 & 2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-User: 6.2.1. Hospitals 6.2.2. Ambulatory Surgical Centers 6.2.3. Specialty Clinics Chapter 7. Neurovascular Embolization Devices Market Segmentation 6: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Neurovascular Embolization Devices Market revenue (US$ Million) estimates and forecasts By Product Type, 2024- 2031 7.1.2. North America Neurovascular Embolization Devices Market revenue (US$ Million) estimates and forecasts By End-User, 2024- 2031 7.1.3. North America Neurovascular Embolization Devices Market revenue (US$ Million) estimates and forecasts by country, 2024- 2031 7.2. Europe 7.2.1. Europe Neurovascular Embolization Devices Market revenue (US$ Million) By Product Type, 2024- 2031 7.2.2. Europe Neurovascular Embolization Devices Market revenue (US$ Million) By End-User, 2024- 2031 7.2.3. Europe Neurovascular Embolization Devices Market revenue (US$ Million) by country, 2024- 2031 7.3. Asia Pacific 7.3.1. Asia Pacific Neurovascular Embolization Devices Market revenue (US$ Million) By Product Type, 2024- 2031 7.3.2. Asia Pacific Neurovascular Embolization Devices Market revenue (US$ Million) By End-User, 2024- 2031 7.3.3. Asia Pacific Neurovascular Embolization Devices Market revenue (US$ Million) by country, 2024- 2031 7.4. Latin America 7.4.1. Latin America Neurovascular Embolization Devices Market revenue (US$ Million) By Product Type, 2024- 2031 7.4.2. Latin America Neurovascular Embolization Devices Market revenue (US$ Million) By End-User, 2024- 2031 7.4.3. Latin America Neurovascular Embolization Devices Market revenue (US$ Million) by country, 2024- 2031 7.5. Middle East & Africa 7.5.1. Middle East & Africa Neurovascular Embolization Devices Market revenue (US$ Million) By Product Type, 2024- 2031 7.5.2. Middle East & Africa Neurovascular Embolization Devices Market revenue (US$ Million) By End-User, 2024- 2031 7.5.3. Middle East & Africa Neurovascular Embolization Devices Market revenue (US$ Million) by country, 2024- 2031 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Acandis GmBH 8.2.2. Braun 8.2.3. BALT Extrusion 8.2.4. Emboflu 8.2.5. Stryker 8.2.6. Johnson & Johnson (Cerenovus) 8.2.7. KLS Martin 8.2.8. Medtronic Plc 8.2.9. Mizuho Medical 8.2.10. Peter Lazic GmBH 8.2.11. Phenox GmBH 8.2.12. Spartan Micro 8.2.13. Terumo Corporation (MicroVention)

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們